If all of that is the case. Then wouldn’t that mean no share price appreciation upon FDA approval?
Ann: Investor Webinar Presentation, page-38
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.005(1.19%) |
Mkt cap ! $757.3M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.0¢ | 41.0¢ | $1.522M | 3.625M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 770879 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 228614 | 8 |
View Market Depth
| Last trade - 11.09am 16/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |